Article
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival.
Clinical lung cancer - 1 Sept 2022
Cucchiara Federico, Petrini Iacopo, Passaro Antonio, Attili Ilaria, Crucitta Stefania, Pardini Eleonora, de Marinis Filippo, Danesi Romano, Del Re Marzia
Abstract excerpt
BACKGROUND: Small cell lung cancer (SCLC) is an aggressive tumor, and despite its sensitivity to chemotherapy and radiotherapy, patients usually have a short survival. There are no clinically relevant predictive factors of responses to therapies, and therapeutic options are still limited. MATERIALS AND METHODS: Clinical data and somatic mutations of genes included in the MSK-IMPACT panel were retrieved from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
